Clinical trials
Terminated Carcinoma, Transitional Cell trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2010 | 1 |
| 2015 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 12 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Astellas Pharma Global Development, Inc. | 2 |
| Hoffmann-La Roche | 2 |
| Incyte Corporation | 2 |
| Bristol-Myers Squibb | 1 |
| Centre Hospitalier Universitaire de Saint Etienne | 1 |
| G1 Therapeutics, Inc. | 1 |
| Gustave Roussy, Cancer Campus, Grand Paris | 1 |
| Rainier Therapeutics | 1 |
| pharmaand GmbH | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Transitional Cell | 12 |
| Urinary Bladder Neoplasms | 6 |
| Ureteral Neoplasms | 2 |
| Urethral Neoplasms | 2 |
| Acrocephalosyndactylia | 1 |
| Carcinoma in Situ | 1 |
| Neoplasm Metastasis | 1 |
| Non-Muscle Invasive Bladder Neoplasms | 1 |
| Urinary Bladder Diseases | 1 |
| Urologic Diseases | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.